(Image/LinkedIn) Fintech infrastructure firm Juspay is on track to become the first unicorn of 2025, targeting a valuation of over $1 billion in its latest funding round. The round, nearing ...
In February 2024, Juspay received authorisation from the Reserve Bank of India to operate as a payment aggregator (PA). Fintech infrastructure firm Juspay is set to become the first unicorn of ...
Google will phase out Chrome Sync for browser versions older than 4 years (pre-2021) in 2025. A modern, automatic sync model (introduced August 2023) replaces the outdated 2009 system, eliminating ...
Poopsie Slime Surprise Unicorn Rainbow Bright Star Or Oopsie Starlight on sale, Poopsie Slime Surprise Unicorn Rainbow Bright Star Or Oopsie Starlight on sale ...
A New York Times story this week chronicled a 28-year-old woman in a relationship with an AI boyfriend who has more sensitivity than the real thing. And the Globe just resurfaced a much-shared ...
The following are the most important versions or translations of the Bible. 1. Septuagint. The oldest Greek translation of the Hebrew Old Testament is known as the Septuagint, and was made between ...
IFLScience on MSN1d
66-Million-Year-Old Fossilized Animal Puke Found Near Famous Danish CliffsT he Stevns Klint (Cliffs of Stevns) in Denmark are perhaps best known for providing evidence of the dinosaur-ending ...
But behind every success story is the need for the right opportunity at the right time. That’s where Leap to Unicorn, an initiative by IDFC FIRST Bank in association with Moneycontrol and CNBC-TV18, ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
Fintech infrastructure firm Juspay is set to become the first unicorn of 2025 as it aims to raise $150 million in its latest funding round, led by Kedaara Capital with participation from WestBridge ...
The supreme court of India quashed proceedings against a firm accused of manufacturing sub-standard drugs, ruling that the trial court's summoning order lacked reasoning. Justices B R Gavai and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback